Ocular Therapeutix Files 8-K on Financials
Ticker: OCUL · Form: 8-K · Filed: May 5, 2025 · CIK: 1393434
| Field | Detail |
|---|---|
| Company | Ocular Therapeutix, Inc (OCUL) |
| Form Type | 8-K |
| Filed Date | May 5, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-K
Related Tickers: OCUL
TL;DR
OCUL filed an 8-K on May 5, 2025, detailing financial results and condition.
AI Summary
Ocular Therapeutix, Inc. filed an 8-K on May 5, 2025, reporting on its results of operations and financial condition, as well as filing financial statements and exhibits. The company, incorporated in Delaware with its principal executive offices in Bedford, MA, is in the pharmaceutical preparations industry.
Why It Matters
This filing provides investors with crucial updates on Ocular Therapeutix's financial performance and condition, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial reporting filing with no immediate new material events disclosed.
Key Players & Entities
- OCULAR THERAPEUTIX, INC (company) — Filer
- May 5, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 15 Crosby Drive Bedford, MA 01730 (address) — Principal Executive Offices
- 781-357-4000 (phone_number) — Company Telephone Number
FAQ
What specific financial information is being reported in this 8-K?
The 8-K indicates it covers 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was this 8-K filing submitted?
The filing was submitted on May 5, 2025.
What is Ocular Therapeutix, Inc.'s state of incorporation?
Ocular Therapeutix, Inc. is incorporated in Delaware.
Where are Ocular Therapeutix, Inc.'s principal executive offices located?
The principal executive offices are located at 15 Crosby Drive, Bedford, MA 01730.
What is the company's SIC code?
The Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 5, 2025 regarding OCULAR THERAPEUTIX, INC (OCUL).